InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by TRABER PETER G, Directeur Médical. Director active across 2 companies, notably Selecta Biosciences INC. In total, 20 reports have been logged. Total volume traded: €266k. The latest transaction was filed on 10 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations20 total
065,430 shares0
Common Stock
SEC:0001284500-22-000003·
065,430 shares0
Common Stock
SEC:0001284500-22-000003:0·
€8,8233,226 shares@ €2.73486.6% of flow
Common Stock
SEC:0001453687-22-000034·
€8,8233,226 shares@ €2.73483.3% of flow
Common Stock
SEC:0001453687-22-000034:0·
090,200 shares0
Common Stock
SEC:0001453687-22-000025·
090,200 shares0
Common Stock
SEC:0001453687-22-000025:0·
€10,7994,083 shares@ €2.64488.1% of flow
Common Stock
SEC:0001453687-21-000186·
€10,7994,083 shares@ €2.64484.1% of flow
Common Stock
SEC:0001453687-21-000186:0·
013,750 shares0
Common Stock
SEC:0001453687-21-000176·
013,750 shares0
Common Stock
SEC:0001453687-21-000176:0·
€13,7613,636 shares@ €3.784610.4% of flow
Common Stock
SEC:0001453687-21-000144·
€13,7613,636 shares@ €3.78465.2% of flow
Common Stock
SEC:0001453687-21-000144:0·
013,750 shares0
Common Stock
SEC:0001453687-21-000135·
013,750 shares0
Common Stock
SEC:0001453687-21-000135:0·
09,100 shares0
Common Stock
SEC:0001453687-21-000121·
09,100 shares0
Common Stock
SEC:0001453687-21-000121:0·
€65,49120,000 shares@ €3.274549.3% of flow
Common Stock
SEC:0001453687-21-000078·
Ideal exit: 20 Feb 2022 (T+270)
€65,49120,000 shares@ €3.274524.6% of flow
Common Stock
SEC:0001453687-21-000078:0·
Ideal exit: 20 Feb 2022 (T+270)
€33,97412,500 shares@ €2.717925.6% of flow
Common Stock
SEC:0001453687-21-000074·
Ideal exit: 18 Feb 2022 (T+270)
€33,97412,500 shares@ €2.717912.8% of flow
Common Stock
SEC:0001453687-21-000074:0·
Ideal exit: 18 Feb 2022 (T+270)
20 of 20 declarations
About TRABER PETER G
Peter G Traber is an executive at Selecta Biosciences Inc.
